CRISPR-Cas9 – mycolab.ai

The role of Micro-biome engineering in enhancing Food safety and quality

mycolabadmin

Microbiome engineering uses advanced biotechnology to strategically modify helpful bacteria in food to make it safer and higher quality. By using tools like CRISPR gene editing and engineering beneficial probiotics, scientists can prevent food spoilage, reduce harmful bacteria, improve nutrition, and create better-tasting foods. These innovations could reduce reliance on synthetic preservatives and chemicals while addressing global food safety challenges and helping combat malnutrition.

Edible mushrooms as emerging biofactories for natural therapeutics and oral biopharmaceutical delivery

mycolabadmin

Mushrooms are emerging as natural medicine factories that can be genetically engineered to produce medications taken by mouth. Beyond their traditional use as health foods, scientists are now using advanced genetic techniques to program mushrooms to manufacture therapeutic proteins and vaccines. These engineered mushrooms can naturally package and protect these medications as they pass through the stomach, releasing them safely in the intestines for absorption. This approach offers a sustainable, affordable, and cold-chain-independent alternative to conventional injected medications.

High-Yield-Related Genes Participate in Mushroom Production

mycolabadmin

Scientists have identified specific genes that control how mushrooms grow and produce fruit bodies. By using advanced gene-editing technology like CRISPR-Cas9, researchers can now increase mushroom yields by 20-65%, offering a faster and more efficient alternative to traditional breeding methods. This breakthrough could help meet the world’s growing demand for mushrooms while making farming more sustainable and economical for growers globally.

Advanced Fungal Biotechnologies in Accomplishing Sustainable Development Goals (SDGs): What Do We Know and What Comes Next?

mycolabadmin

Fungi are remarkable organisms with tremendous untapped potential for solving global challenges. They can be engineered to produce life-saving medicines like antibiotics and cholesterol-lowering drugs, create nutritious food alternatives, clean up polluted environments, and help fight climate change. As we transition to more sustainable living practices, fungi represent a natural solution that has been used for centuries but is only now being fully appreciated through modern biotechnology.

Snowball: a novel gene family required for developmental patterning of fruiting bodies of mushroom-forming fungi (Agaricomycetes)

mycolabadmin

Scientists discovered a new gene called snb1 that is critical for mushroom development. When this gene is removed, mushrooms grow into simple ball-shaped structures without the normal parts like caps and stems. By studying these abnormal mushrooms, researchers identified many other genes involved in proper mushroom formation. This discovery helps explain how mushrooms develop their complex structures from simple fungal networks.

Providing a toolbox for genomic engineering of Trichoderma aggressivum

mycolabadmin

Scientists have created a set of tools to genetically engineer Trichoderma aggressivum, a fungus that causes green mold disease in cultivated mushrooms but can also be used beneficially. The study provides step-by-step methods for transforming this fungus using both traditional plasmid methods and modern CRISPR gene-editing technology. These tools will help researchers understand how the fungus works and potentially harness its beneficial properties for agriculture.

Towards engineering agaricomycete fungi for terpenoid production

mycolabadmin

Mushroom-forming fungi, particularly species like shiitake and oyster mushrooms, naturally produce valuable compounds called terpenoids used in medicines, food, and cosmetics. Scientists are learning to genetically engineer these fungi to produce even larger amounts of these beneficial compounds, potentially making them as important to biotechnology as baker’s yeast and mold have been historically. This could create new sustainable sources for medicinal compounds and industrial chemicals.

Orthrus: a Pumilio-family gene involved in fruiting body and dark stipe development in Coprinopsis cinerea

mycolabadmin

Scientists studied a gene called ort2 in a common lab mushroom species to understand how mushrooms develop their fruiting bodies. They found that this gene is particularly important for developing dark stipes – elongated structures that mushrooms grow in darkness to push themselves toward light. By turning this gene off or increasing its activity, researchers could control how many dark stipes formed, suggesting this gene could have practical applications in mushroom farming.

Improved Protoplast Production Protocol for Fungal Transformations Mediated by CRISPR/Cas9 in Botrytis cinerea Non-Sporulating Isolates

mycolabadmin

Scientists have developed a better method to isolate protoplasts (fungal cells without cell walls) from non-sporulating varieties of gray mold fungus. By optimizing the incubation time, culture container, and enzyme used, they produced more viable protoplasts that can regenerate and be genetically modified. This advancement allows researchers to use CRISPR gene-editing technology to understand and potentially control gray mold, which causes significant crop losses worldwide.

Aokap9 gene knockout contributes to kojic acid synthesis in Aspergillus oryzae

mycolabadmin

Researchers discovered that removing the Aokap9 gene in the fungus Aspergillus oryzae doubles the production of kojic acid, a valuable chemical used in skin-whitening cosmetics and food preservation. By combining the Aokap9 gene removal with modifications to other genes (kojR and AozfA), they achieved even higher production levels. This research provides a practical pathway for creating high-yield strains that can produce kojic acid more efficiently for commercial applications.

Research Topic: CRISPR-Cas9